New GMFH “best of” document presents current progress and health applications of synbiotics

Synbiotics are substances that combine a probiotic and prebiotic. While Gibson and Roberfroid were the first to anticipate that the two could be combined as synbiotics back in 1995, research in the field has accelerated over the past decade.

The reported scientific literature on synbiotics includes a wide range of studies carried out under different conditions. Recent human trials have used synbiotics to treat specific clinical disorders that include inflammatory bowel diseases, metabolic syndrome, diarrhea, colon cancer, irritable bowel syndrome, and kidney and liver diseases.

With an editorial from ISAPP’s Executive Science Officer Mary Ellen Sanders and science writer and health communication consultant Andreu Prados, this document contains a selection of human studies on the health benefits of synbiotics, along with advice for identifying high quality probiotics.

You can also stay up-to-date on the latest developments and opportunities in the field by following Gut Microbiota for Health-related resources and @GMFHx on Twitter.

Avatar
GMFH Editing Team
GMFH Editing Team